NCT03729024View on ClinicalTrials.gov

Exploratory Study to Evaluate Uncorrected Distance Vision and Quality of Vision After Light Treatments of an Implanted RxSight Light Adjustable Lens (RXLAL) With The Light Delivery Device (LDD) in Subjects With Preoperative Corneal Astigmatism

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 26, 2018

Primary Completion Date

April 15, 2019

Study Completion Date

February 4, 2020

Conditions

AphakiaCataract

Interventions

DEVICE

Light Adjustable lens (LAL) and Light Delivery Device (LDD)

Primary and Fellow eyes will receive Light adjustable lens with Light delivery Device treatments

Trial Locations (1)

Unknown

CODET Vision Institute, Tijuana

All Listed Sponsors

lead

RxSight, Inc.

INDUSTRY

NCT03729024 - Exploratory Study to Evaluate Uncorrected Distance Vision and Quality of Vision After Light Treatments of an Implanted RxSight Light Adjustable Lens (RXLAL) With The Light Delivery Device (LDD) in Subjects With Preoperative Corneal Astigmatism | Biotech Hunter | Biotech Hunter